Blueberries Medical Corp.
BBRRF
$0.009
-$0.0023-20.35%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 331.66% | -28.14% | -17.96% | 14.41% | 4.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 331.66% | -28.14% | -17.96% | 14.41% | 4.52% |
| Cost of Revenue | 1,704.11% | -81.45% | 8.36% | -24.01% | 154.48% |
| Gross Profit | 57.92% | 179.53% | -52.58% | 293.90% | -34.05% |
| SG&A Expenses | -43.49% | -8.35% | -33.04% | -12.96% | 33.04% |
| Depreciation & Amortization | -24.51% | -73.76% | 2,137.50% | 92.31% | 483.58% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.02% | -34.66% | -22.86% | -11.69% | 61.91% |
| Operating Income | 54.52% | 36.21% | 23.90% | 18.20% | -76.54% |
| Income Before Tax | 0.76% | 46.50% | 34.64% | 41.26% | -5,773.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.76% | 46.50% | 34.64% | 41.26% | -5,773.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.76% | 46.50% | 34.64% | 41.26% | -5,773.47% |
| EBIT | 54.52% | 36.21% | 23.90% | 18.20% | -76.54% |
| EBITDA | 57.66% | 21.17% | 31.27% | 23.41% | -139.57% |
| EPS Basic | 46.15% | 72.73% | 64.71% | 66.67% | -- |
| Normalized Basic EPS | 50.00% | 71.43% | 63.64% | 66.67% | -300.00% |
| EPS Diluted | 46.15% | 72.73% | 64.71% | 66.67% | -- |
| Normalized Diluted EPS | 50.00% | 71.43% | 63.64% | 66.67% | -300.00% |
| Average Basic Shares Outstanding | 79.52% | 82.78% | 82.78% | 82.78% | 20.72% |
| Average Diluted Shares Outstanding | 79.52% | 82.78% | 82.78% | 82.78% | 20.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |